Daiichi Sankyo Company, Limited (DSNKY)
OTCMKTS · Delayed Price · Currency is USD
23.83
-1.53 (-6.03%)
Oct 31, 2025, 4:00 PM EDT
Daiichi Sankyo Company Market Cap
Daiichi Sankyo Company has a market cap or net worth of $44.06 billion as of October 31, 2025. Its market cap has decreased by -29.72% in one year.
Market Cap
44.06B
Enterprise Value
41.85B
Revenue
13.37B
Ranking
n/a
PE Ratio
23.30
Stock Price
$23.83
Market Cap Chart
Since September 28, 2005, Daiichi Sankyo Company's market cap has increased from 2.93B to 44.06B, an increase of 1,405.87%. That is a compound annual growth rate of 14.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 44.06B | -15.52% |
| Dec 30, 2024 | 52.16B | -0.97% |
| Dec 29, 2023 | 52.67B | -14.75% |
| Dec 30, 2022 | 61.78B | 26.88% |
| Dec 30, 2021 | 48.69B | -26.63% |
| Dec 30, 2020 | 66.36B | 54.24% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 660.18M |
| Glass House Brands | 563.78M |
| Northwest Biotherapeutics | 377.06M |
| Silence Therapeutics | 338.20M |
| Nika Pharmaceuticals | 311.89M |
| American Oncology Network | 302.09M |
| CytoDyn | 297.30M |